Search filters

List of works by Ryuji Hamamoto

Application of non-negative matrix factorization in oncology: one approach for establishing precision medicine

scientific article published in 2022

Automethylation of SUV39H2, an oncogenic histone lysine methyltransferase, regulates its binding affinity to substrate proteins

scientific article published on 14 March 2016

Critical roles of SMYD2-mediated β-catenin methylation for nuclear translocation and activation of Wnt signaling

scientific article published on 27 July 2017

Critical roles of non-histone protein lysine methylation in human tumorigenesis

scientific article

Dysregulation of protein methyltransferases in human cancer: An emerging target class for anticancer therapy

scientific article

Effects of SMYD2-mediated EML4-ALK methylation on the signaling pathway and growth in non-small-cell lung cancer cells

scientific article

Functional Genomics, Genetics, and Bioinformatics 2016

scientific article

Functional genomics, genetics, and bioinformatics.

scientific article published on 22 April 2015

Heterogeneity of Serum and Amniotic Fluid Prolactin in Humans

scientific article published on January 1, 1991

Histone lysine methyltransferase SETD8 promotes carcinogenesis by deregulating PCNA expression

scientific article published on May 3, 2012

PRMT6 increases cytoplasmic localization of p21CDKN1A in cancer cells through arginine methylation and makes more resistant to cytotoxic agents

scientific article published on 3 September 2015

SUV39H2 methylates and stabilizes LSD1 by inhibiting polyubiquitination in human cancer cells

scientific article published on July 2015

SUV420H1 enhances the phosphorylation and transcription of ERK1 in cancer cells

scientific article published on 19 November 2015

The LSD1 Family of Histone Demethylases and the Pumilio Posttranscriptional Repressor Function in a Complex Regulatory Feedback Loop

scientific article

The histone methyltransferase SMYD2 is a novel therapeutic target for the induction of apoptosis in ovarian clear cell carcinoma cells

scientific article published on 24 August 2020

The metabolic stress-activated checkpoint LKB1-MARK3 axis acts as a tumor suppressor in high-grade serous ovarian carcinoma

scientific article published on 11 January 2022

The oncogenic polycomb histone methyltransferase EZH2 methylates lysine 120 on histone H2B and competes ubiquitination

scientific article published on November 2013

Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker

scientific article published on May 26, 2011